Figure 1.

Trial profile. Footnote: PHiD-CV group= infants vaccinated with PHiD-CV co-administered with DTPa-HBV-IPV/Hib at 2, 3, and 4 months of age. Control group= infants vaccinated with DTPa-HBV-IPV/Hib at 2, 3, and 4 months of age. N= number of infants.

Huu et al. BMC Infectious Diseases 2013 13:95   doi:10.1186/1471-2334-13-95
Download authors' original image